UK markets close in 1 hour 52 minutes

Design Therapeutics, Inc. (DSGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.7900+0.1400 (+3.84%)
As of 09:38AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-57,033
-66,862
-63,308
-35,533
-8,280
Depreciation & amortisation
364
537
406
129
5
Stock-based compensation
9,405
13,088
10,925
4,689
450
Change in working capital
2,215
728
1,992
1,396
-811
Accounts payable
4,936
-1,246
5,385
2,413
-413
Other working capital
-46,437
-58,816
-52,235
-30,915
-8,745
Other non-cash items
67
33
64
19
38
Net cash provided by operating activities
-45,453
-58,560
-51,317
-29,377
-8,669
Cash flows from investing activities
Investments in property, plant and equipment
-984
-256
-918
-1,538
-76
Purchases of investments
-301,895
-224,703
-312,998
-86,261
-55,589
Sales/maturities of investments
32,850
277,495
92,890
34,155
22,104
Other investing activities
-
-
39
-
-
Net cash used for investing activities
-269,990
52,536
-220,987
-53,644
-33,561
Cash flows from financing activities
Debt repayment
-
-
-
0
-400
Common stock issued
0
-
0
254,271
0
Other financing activities
-
-
-427
-
-
Net cash used provided by (used for) financing activities
298
724
235
379,211
44,532
Net change in cash
-315,145
-5,300
-272,069
296,190
2,302
Cash at beginning of period
357,662
26,500
298,569
2,379
77
Cash at end of period
42,517
21,200
26,500
298,569
2,379
Free cash flow
Operating cash flow
-45,453
-58,560
-51,317
-29,377
-8,669
Capital expenditure
-984
-256
-918
-1,538
-76
Free cash flow
-46,437
-58,816
-52,235
-30,915
-8,745